Position in DXCM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,323,572
+$362,668 QoQ
Shares Held
21,076
+45.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026&PARTNERS holds $136,442,788 across 21 Medical Devices names. DXCM ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
576,145 | $59,152,807 | |
| 2 | MDT |
Medtronic plc
|
468,613 | $40,605,316 | |
| 3 | SYK |
Stryker Corp
|
55,491 | $18,233,787 | |
| 4 | BSX |
Boston Scientific Corp
|
69,266 | $4,346,441 | |
| 5 | EW |
Edwards Lifesciences Corp
|
24,525 | $1,963,962 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
21,527 | $1,946,471 | |
| 7 | SNN |
Smith & Nephew PLC
|
58,912 | $1,872,223 | |
| 8 | DXCM |
Dexcom Inc
This page
|
21,076 | $1,323,572 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,323,572 | 21,076 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $960,904 | 14,478 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,473,583 | 21,899 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,898,557 | 21,750 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,565,206 | 22,920 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,149,285 | 14,778 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $799,049 | 11,919 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,079,037 | 9,517 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||